1. 'Pulse' methylprednisolone and cyclophosphamide therapy in idiopathic rapidly progressive glomerulonephritis. Issue 663 (January 1981) Authors: Friedman, G.; Granot, H.; Koplovic, Y.; Friedlander, M. Journal: Postgraduate medical journal Issue: Volume 57:Issue 663(1981) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 00011 PHASE II STUDY OF FIRST-LINE CARBOPLATIN FOLLOWED SEQUENTIALLY BY GEMCITABINE AND PACLITAXEL IN ADVANCED OVARIAN CANCER: AN AUSTRALIAN AND NEW ZEALAND GYNAECOLOGICAL ONCOLOGY GROUP STUDY. (1st September 2005) Authors: Friedlander, M.; Harnett, P.; Findlay, M.; Wyld, D.; Buck, M. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2759 Management of nausea and vomiting during treatment with the capsule (CAP) and tablet (TAB) formulations of the PARP inhibitor olaparib. (September 2015) Authors: Banerjee, S.; Ledermann, J.; Matulonis, U.; Molife, L.R.; Friedlander, M.; Fielding, A.; Robertson, J.D.; Spencer, S.; McMurtry, E.; Kaye, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A decision aid for women at increased risk for ovarian cancer. Issue 1 (1st January 2003) Authors: Tiller, K.; Meiser, B.; Reeson, E.; Tucker, M.; Andrews, L.; Gaff, C.; Kirk, J.; Phillips, K. A.; Friedlander, M. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Brachial Plexus Block. Issue 4654 (18th March 1950) Authors: Devitt, D. C.; Friedlander, M.; Kramer, M. S.; Vareges, L.; Sutherland, J. G. W.; Rosenberg, J. Journal: BMJ Issue: Volume 1:Issue 4654(1950) Page Start: 670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Chemoprevention for breast cancer: A survey of the views of Australian women and clinicians. (October 2020) Authors: Macdonald, C.; Mazza, D.; Hunter, M.; Keogh, L.A.; Milne, R.; Hickey, M.; Saunders, C.; McLachlan, S.A.; Friedlander, M.; Hopper, J.; Emery, J.; Jones, S.; Phillips, K.A. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Exploring knowledge, attitudes and experience of genitourinary symptoms in women with early breast cancer on adjuvant endocrine therapy. (16th January 2018) Authors: Sousa, M.; Peate, M.; Lewis, C.; Jarvis, S.; Willis, A.; Hickey, M.; Friedlander, M. Journal: European journal of cancer care Issue: Volume 27:Number 2(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high grade ovarian carcinoma on the ARIEL2 trial. (December 2016) Authors: Piskorz, A.M.; Lin, K.K.; Morris, J.; Mann, E.; Oza, A.; Coleman, R.L.; O'Malley, D.M.; Friedlander, M.; Cragun, J.M.; Ma, L.; Giordano, H.; Raponi, M.; McNeish, I.A.; Swisher, E.; Brenton, J.D. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Is quantification of lymphovascular space invasion useful in stage 1B2 cervical carcinomas?. (May 2015) Authors: Scurry, J.; Hacker, N. F.; Barlow, E.; Friedlander, M.; Jackson, M. Journal: Journal of obstetrics and gynaecology Issue: Volume 35:Number 4(2015) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer. Issue 2 (1st February 2007) Authors: Friedlander, M.; Buck, M.; Wyld, D.; Findlay, M.; Fitzharris, B.; De Souza, P.; Davies, T.; Kalimi, G.; Allan, S.; Perez, D.; Harnett, P. Journal: International journal of gynecological cancer Issue: Volume 17:Issue 2(2007) Page Start: 350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗